Efficacy of mesalazine in the treatment of symptomatic diverticular disease

Digestive Diseases and Sciences

Volumn 50, Issue 3, 2005, Pages 581-586

  Mario, Francesco Di ^a   Aragona, Giovanni ^a   Leandro, Gioacchino ^b   Comparato, Giuseppe ^a   Fanigliulo, Libera ^a   Cavallaro, Lucas G ^a   Cavestro, Giulia M ^a   Iori, Veronica ^a   Maino, Marta ^a   Moussa, Alì M ^a   Gnocchi, Alessandro ^c   Mazzocchi, Giancarlo ^d   Franzé, Angelo ^c  

^a UNIVERSITY OF PARMA   (Italy)

^b NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

^c Az Ospedaliera   (Italy)

^d AUSL   (Italy)

Author keywords

Diverticula; Diverticular disease; Mesalazine; Rifaximin

Indexed keywords

MESALAZINE; RIFAXIMIN;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOATING; CLINICAL TRIAL; COLON DIVERTICULOSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEFECATION DISORDER; DIARRHEA; DIGESTIVE TRACT PARAMETERS; DRUG EFFICACY; DRUG MEGADOSE; DYSURIA; FEMALE; FEVER; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OUTPATIENT; PALLIATIVE THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SIDE EFFECT; TREATMENT OUTCOME; VOMITING;

ADMINISTRATION, ORAL; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; DIVERTICULITIS, COLONIC; DIVERTICULUM, COLON; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTESTINAL MUCOSA; MALE; MESALAMINE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RIFAMYCINS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 20244368344     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2478-z     Document Type: Article

References (36)

1. Stollman NH, Baskin JB, for and on behalf of the Ad Hoc Practice Parameters Committee of the American College of Gastroenterology: Diagnosis and management of diverticular disease of the colon in adults. Practice guidelines. Am J Gastroenterol 94(11):3110-3121, 1999
2. American Gastroenterological Association: The Burden of Gastrointestinal Disease. Bethesda, MD, American Gastroenterological Association, 2001
3. Almy TP, Howell DA: Diverticular disease of the colon. N Engl J Med 302:324-331, 1980
4. Kohler L, Sauerland S, Neugebauer E, for the Scientific Committee of the European Association for Endoscopie Surgery: Diagnosis and treatment of diverticular disease. Results of a consensus development conference. Surg Endosc 13:430-436, 1999
5. Schwartz JT, Graham DY: Diverticular disease of the large intestine. In Diseases of the Colon, Rectum and Anal Canal. J Kirsner, R Shorter (eds). Baltimore, Williams & Wilkins, 1998, pp 519-536
6. Naitove A, Smith RE: Diverticular disease of the colon. In Gastrointestinal Disease, 5th ed. MH Sleisenger, TS Fordtran (eds). Philadelphia, Saunders, 1993, pp 1347-1363
7. Fleischner FG, Ming SC: Revised concepts on diverticular disease of the colon. II. So-called diverticulitis: diverticular sigmoiditis and perisigmoiditis, diverticular abscesses, fistula and frank peritonitis. Radiology 84:599-609, 1965
8. Torsoli A, Inoue M, Manousos O, Smith A, Van Steensel CJ: Diverticular disease of the colon: data relevant to treatment. Gastroenterol Int 4:3-20, 1991
9. Brodribb AJ: Treatment of symptomatic diverticular disease with a high-fibre diet. Lancet 1(8013):664-666, 1977
10. Ewerth S, Ahlberg J, Holmstrom B, Persson U, Uden R: Influence on symptoms and transit time of Vi SiblinR in diverticular disease. Acta Chir Scand 500:40-59, 1980
11. Solotoft J, Gudmand-Hoyer E, Krag B, Kristensen E, Wulff HR: A double blind trial of wheat bran on symptoms of irritable bowel syndrome. Lancet 1(7954):270-272, 1976
12. Longstregth GF, Fox DD, Youkeles L, Forsythe AB, Wolochow DA: Psyllium therapy in the irritable bowel syndrome. Ann Intern Med 95:53-56, 1981
13. Ritchie L: Similarity of bowel distension characteristics in the irritable bowel syndrome and diverticulosis. Gut 18:990, 1997
14. Papi C, Ciaco A, Koch M, Capurso L: Diverticular Disease Study Group Efficacy of rifaximin on symptoms of uncomplicated diverticular disease of the colon. A pilot multicentre open trial. Ital J Gastroenterol 24:452-456, 1992
15. Papi C, Ciaco A, Koch M, Capurso L: Efficacy of rifaximin in the treatment of symptomatic diverticular disease of the colon. A multicentre double-blind placebo-controlled trial. Aliment Pharmacol Ther 9:33-39, 1995
16. Latella G, Pimpo MT, Sottili S, Zippi M, Viscido A, Chiaramonte M, Frieri G: Rifaximin improves symptoms of acquired uncomplicated diverticular disease of the colon. Int J Colorectal Dis 18:55-62, 2003
17. Iosca N, Ferrieri A: Terapia e profilassi con rifaximina degli episodi di diverticolite acuta. Recenti Prog Med 84(1):42-53, 1993
18. Kurpad AV, Shetty PS: Effects of antimicrobial therapy on faecal bulking. Gut 27:55-58, 1997
19. Ventrucci M, Ferrieri A, Roda E: Evaluation of the effect of rifaximin in colon diverticular disease by means of lactulose hydrogen breath test. Curr Med Res Opin 13:202-206, 1994
20. Rogler G, Andus T: Cytokines in inflammatory bowel disease. World J Surg 22:382-389, 1998
21. Izzo AA, Mascolo N, Capasso F: Nitric oxide as a modulator of intestinal water and electrolyte transport. Dig Dis Sci 43:1605-1620, 1998
22. Gore S, Sheperd NA, Wilkinson SP: Endoscopic crescentic fold disease of the sigmoid colon: the clinical and hystopathological spectrum of a distinctive endoscopic appearance. Int J Colored Dis 7:76-81, 1992
23. Makapugay LM, Dean PJ: Diverticular disease-associated chronic colitis. Am J Surg Pathol 20(1):94-102, 1996
24. Sheperd NA: Diverticular disease and chronic idiopathic inflammatory bowel disease: associations and masquerades. Gut 38:801-802, 1996
25. Trespi E, Colla C, Panizza P, Polino MG, Venturini A, Bottani G, De Vecchi P, Matti C: Ruolo terapeutico e profilattico della mesalazina (5-ASA) nella malattia diverticolare sintomatica del crasso. Minerva Gastroenterol Dietol 45:245-252, 1999
26. Tursi A, Brandimarte G, Daffinà R: Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon. Dig Liver Dis 34:510-515, 2002
27. Peppercorn MA: Drug-responsive chronic segmental colitis associated with diverticula: a clinical syndrome in the elderly. Am J Gastroenterol 87:609-612, 1992
28. Brandt LJ: The colon. In Gastrointestinal Disorders of the Elderly. LJ Brandt (ed). New York, Raven Press, 1984, pp 261-367
29. Marshak RH, Janowitz HD, Present DH: Granulomatous colitis in association with diverticula. N Engl J Med 283:1080-1084, 1970
30. Marshak RH, Lindner AE, Maklansky D: Paracolic fistulous tracts in diverticulitis and granulomatous colitis. JAMA 243:1943-1946, 1980
31. McCue J, Coppen MJ, Rasbridge SA, et al.: Coexistent Crohn's disease and sigmoid diverticulitosis. Postgrad Med J 65:636-639, 1989
32. Meyers MA, Alonso DR, Morson BC, Bartram C: Pathogenesis of diverticulitis complicating granulomatous colitis. Gastroenterology 74:24-31, 1978
33. Schmidt GT, Lennard-Jones JE, Morson BC, Young AC: Crohn's disease of the colon an dits distinction from diverticulitis. Gut 9:7-16, 1968
34. Spiliadis CA, Spiliadis CA, Lennard-Jones JE: Ulcerative colitise with relative sparing of the rectum. Dis Colon Rectum 30:334-336, 1987
35. Morson BC, Dawson IMP, Day DW, Jass JR, Price AB, Williams Gt: Inflammatory disorders. In Gastrointestinal Pathology, 3rd ed. Morson, Dawson (eds). Oxford, Blackwell Scientific, 1990, p 521
36. Lee FD, Maguire C, Obeidat W, Russel RI: The significance of cryptolytic lesions in inflammatory bowel disease. Gut 37:21A, 1995